Acasti Pharma reported $66.58M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Acasti Pharma USD 66.58M 3.22M Sep/2025
Addus HomeCare USD 1.44B 1.61M Mar/2026
Amarin USD 645.76M 25.01M Mar/2026
Cassava Sciences USD 108.37M 9.99M Mar/2026
Knight Therapeutics CAD 1.05B 2.28M Dec/2025
Option Care Health USD 3.38B 75.67M Mar/2026
Organigram Holdings CAD 530.67M 31.54M Dec/2025
Tilray USD 2.1B 15.95M Sep/2025